Abstract
The effect of increasing the time interval between strontium exposure and chelation therapy was studied in male Swiss mice. Diethylenetriaminepentaacetic acid (DTPA), ethyleneglycol-bis(β-amino-ethylether)-N,N′-tetraacetic acid (EGTA), 4,7,13,16,21,24-hexaoxa-1,10-diazabycyclo[8.8.8]-hexacosane (Kryptofix® 222), tartaric acid, and 1,13-bis(8-chinolyl)-1,4,7,10,13-pentaoxatridecan (Kryptofix® 5) were administered intraperitoneally at 0, 6, 12, and 24 h after subcutaneous injection of 1,139 mg/kg of strontium nitrate. Chelating agents were given at doses equal to one-fourth of their respective LD50 values. Daily elimination of strontium into urine and feces was determined for five days after which time the animals were killed, and the concentration of strontium was determined in various tissues. Only Kryptofix 222 was capable of increasing the total urinary elimination of strontium when given immediately after strontium exposure, whereas the amount of total strontium excreted into the feces was significantly enhanced by treatment with EGTA at 0 or 24 h after strontium injection, or with Kryptofix 222 at 6 h after strontium exposure. However, Kryptofix 222, tartaric acid, and Kryptofix 5 reduced the concentration of strontium in bone at 0, 6, or 12 h after strontium injection, whereas at 24 h only Kryptofix 5 significantly lowered the concentration of the metal in bone. The results of this study indicate that the length of time before initiating chelation therapy for strontium removal may influence remarkably the effectiveness of this therapy.
Similar content being viewed by others
References
Blakely RL (1989) Bone strontium in pregnant and lactating females from archaeological samples. Am J Phys Anthropol 80:173–185
Buschmann HJ (1987) The macrocyclic and cryptate effect. 8. Complex formation of the cryptands (222), (222B), (222BB) and (222CC) with different cations in methanol solutions. Inorg Chim Acta 134:225–228
Catsch A (1967) Removal of radiostrontium from the mammalian body. In: Lenihan JM, Loutit JF, Martin JH (eds) Strontium metabolism. Academic Press, London, pp 265–281
Catsch A, Harmuth-Hoene AE, Mellor DP (1979) The chelation of heavy metals. Pergamon Press, NY
Colomina MT, Llobet JM, Domingo JL, Corbella J (1991) The effects of repeated administration of various chelating agents on the removal of strontium from the mouse. Vet Hum Toxicol 33:121–124
Dietrich B, Lehn JM, Sauvage JP (1969) Les cryptates. Tetrahedron Lett 34:2889–2892
Kostial K, Vnucec M, Tominac C, Simonovic I (1980) A method for simultaneous decrease of strontium, caesium and iodine after oral exposure in rats. Int J Radiat Biol 37:347–350
Kostial K, Kargacin B, Simonovic I (1983) Efficiency of a composite treatment for mixed fission products in rats. J Appl Toxicol 3:291–296
— (1987) Reduced radiostrontium absorption in a human subject treated with composite treatment for mixed fission product contamination. Hlth Phys 52:371–372
Llobet JM, Colomina MT, Domingo JL, Corbella J (1991) Effect of chelating agents on tissue distribution and excretion of strontium following semichronic strontium ingestion. Res Commun Chem Pathol Pharmacol 71:243–246
Ortega A, Gomez M, Domingo JL, Corbella J (1989) The removal of strontium from the mouse by chelating agents. Arch Environ Contam Toxicol 18:612–616
Parks NJ, Book SA, Pool RR (1984) Squamous cell carcinoma in the jaws of beagles exposed to90Sr throughout life: Beta flux measurements at the mandible and tooth surfaces and a hypothesis for tumorigenesis. Radiat Res 100:139–156
Price TD, Swick RN, Chase EP (1986) Bone chemistry and prehistoric diet: Strontium studies of laboratory rats. Am J Phys Anthropol 70: 365–375
Reddi OS (1971) Long term genetic effects of strontium-90 in mice. Indian J Med Res 59:1754–1757
Silva AJ, Fleshman DG, Shore B (1970) The effects of sodium alginate on the absorption and retention of several divalent cations. Hlth Phys 19:245–251
Skoryna SC, Paul TM, Waldron-Edward D (1965) Studies of inhibition of intestinal absorption of radioactive strontium. IV. Estimation of the suppressant effect of sodium alginate. Can Med Assoc J 93:404–407
Spencer H, Feldstein A, Samachson JH (1962) Effect of the chelating agentbis 2-aminoethylether tetraacetate (BAETA) on radiostrontium excretion in man. J Lab Clin Med 59:445–455
Sutton A (1967) Reduction of strontium absorption in man by the addition of alginate to the diet. Nature 216:1005–1007
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Llobet, J.M., Colomina, M.T., Domingo, J.L. et al. Evaluation of the effects of chelation therapy with time following strontium exposure to mice. Arch. Environ. Contam. Toxicol. 21, 612–620 (1991). https://doi.org/10.1007/BF01183885
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF01183885